InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,446.68
(
-1.37%
)
US TECH 100
18,270.40
(
-3.04%
)
Dow Jones
40,347.97
(
-1.21%
)
Brent Oil
80.01
(
-1.85%
)
Bitcoin
64,183.86
(
-0.60%
)
Post# of 892
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Glider549

Send PM Follow Ignore
Followers 22
Posts 1558
Boards Moderated 0
Alias Born 01/23/2014

Glider549

Re: None

Wednesday, 08/14/2019 2:38:40 PM

Wednesday, August 14, 2019 2:38:40 PM

Post# of 892
Tyme Technologies (TYME) is gearing up for many catalysts in the 2nd half of 2019. That's because it has several of them that are approaching in the coming weeks/months. The biotech has already shown positive preliminary data in 3rd line pancreatic cancer and in prostate cancer using its drug SM-88.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM

Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM

VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM

Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM

Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM

Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!